Address
Email address
Phone number
https://arst.eeAVALEHT - Arst.eeHaiguste ja seisundite kataloog Haiguste ja seisundite kataloog Meie veebi haiguste ja seisundite kataloogist saate lugeda erinevate haiguste sümptomite ja ravi kohta. Sisene kataloogi OLULINE! Meie veebis olevad haiguste ja seisundite kirjeldused on vaid informatiivsed. Ärge end veebiinfo põhjal
Name
OÜ Meditiim
Registry code
10718595
VAT number
EE101934716
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.01.2001 (23)
Financial year
01.01-31.12
Capital
5 112.00 €
Activity
86211 - Provision of general medical treatment
2 361 153 €
-280 741 €
-12%
2 121 €
(estimate is approximate)
141 390 €
22
Submitted
No tax arrears
-199%
-14%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Eero Merilind 20.04.1971 (53) | 50% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Kristel Merilind 24.05.1970 (54) | 25% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| Reet Raamat 14.03.1974 (50) | 25% - 1 278.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MTÜ Eesti Esmatasandi Tervisekeskuste Liit 80628250 | - | - | - | Founder (without contribution) |
| 2019 18.10.2020 | 2020 26.06.2021 | 2021 20.06.2022 | 2022 30.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 814 248 € | 881 734 € | 1 100 692 € | 1 897 580 € | 2 361 153 € |
| Net profit (loss) for the period | 222 053 € | 37 918 € | 671 095 € | 134 153 € | -280 741 € |
| Profit Margin | 27% | 4% | 61% | 7% | -12% |
| Current Assets | 293 509 € | 556 468 € | 237 276 € | 346 411 € | 285 841 € |
| Fixed Assets | 198 720 € | 322 642 € | 1 766 370 € | 1 783 021 € | 1 701 074 € |
| Total Assets | 492 229 € | 879 110 € | 2 003 646 € | 2 129 432 € | 1 986 915 € |
| Current Liabilities | 31 533 € | 380 496 € | 416 100 € | 387 246 € | 213 568 € |
| Non Current Liabilities | - | - | 424 777 € | 1 320 250 € | 1 631 957 € |
| Total Liabilities | - | - | 840 877 € | 1 707 496 € | 1 845 525 € |
| Share Capital | - | - | - | - | - |
| Equity | 460 696 € | 498 614 € | 1 162 769 € | 421 936 € | 141 390 € |
| Employees | 12 | 12 | 13 | 19 | 22 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 13 535.85 € | 82 683.29 € | 88 849.02 € | 29 |
| 2023 Q4 | 4 308.69 € | 71 655.77 € | 76 438.59 € | 27 |
| 2023 Q3 | - | 70 062.26 € | 75 654.53 € | 23 |
| 2023 Q2 | - | 52 511.15 € | 56 771 € | 23 |
| 2023 Q1 | - | 54 810.75 € | 58 520.75 € | 20 |
| 2022 Q4 | - | 58 742.26 € | 62 765.53 € | 20 |
| 2022 Q3 | - | 55 527.38 € | 60 047.68 € | 22 |
| 2022 Q2 | - | 33 414.85 € | 53 546.53 € | 22 |
| 2022 Q1 | - | 54 803.82 € | 49 733.24 € | 19 |
| 2021 Q4 | - | - | 35 761.31 € | 16 |
| 2021 Q3 | - | - | 35 446.63 € | 13 |
| 2021 Q2 | 257 810.31 € | - | 34 799.28 € | 12 |
| 2021 Q1 | 250 743.13 € | 18 817.49 € | 29 934.57 € | 13 |
| 2020 Q4 | 235 211.03 € | 19 746.91 € | 29 815.41 € | 13 |
| 2020 Q3 | 227 363.78 € | 23 759.53 € | 25 749.97 € | 13 |
| 2020 Q2 | 211 893.88 € | 24 282.66 € | 26 321.74 € | 12 |
| 2020 Q1 | 166 877.87 € | 27 088.14 € | 28 219.95 € | 13 |
